KZA 0.00% 8.0¢ kazia therapeutics limited

Hi Rinnekin,Matt Dun's Lab would be coordinating the development...

  1. 1,148 Posts.
    lightbulb Created with Sketch. 819
    Hi Rinnekin,

    Matt Dun's Lab would be coordinating the development of a less toxic GD2 CAR T-cell therapy for H3K27M+ DIPG/DMG, in combination with ONC201 and paxalisib (PNOC study).
    Matt Dun previously mentioned in his collaborative discussions that immunotherapy would be needed to knock out and kill the remaining cancer cells for DIPG/DMG.
    I noticed a few months ago he was recruiting an additional lab assistant to research immunotherapy.
    You can draw your own conclusion on his future research for DIPG/DMG.

    Regards.


 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.